Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
918 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo
22 Recruiting Effects of Glucagon Administration on Energy Expenditure
Conditions: Hyperglucagonemia;   Obesity
Interventions: Drug: Glucagon;   Drug: Octreotide;   Behavioral: Placebo;   Drug: Insulin
23 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
24 Recruiting Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention:
25 Recruiting Linagliptin Inpatient Trial
Condition: Type 2 Diabetes
Interventions: Drug: Linagliptin;   Drug: Basal Bolus;   Drug: Linagliptin + glargine 50%;   Drug: Linagliptin + 80% Glargine
26 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
27 Unknown  Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active  titration algorithm;   Behavioral: Usual titration algorithm
28 Not yet recruiting Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy
Condition: Brain Neoplasms
Interventions: Radiation: Partial brain re-irradiation.;   Drug: Metformin;   Behavioral: low carbohydrate diet
29 Not yet recruiting The Practical Evidence of Antidiabetic Combination Therapy in Korea
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: alogliptin;   Drug: Pioglitazone;   Drug: alogliptin + pioglitazone
30 Unknown  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Conditions: Diabetes;   Dyslipidemia;   Inflammation;   Cytokines
Intervention: Drug: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
31 Recruiting Hypoglycemia and Autonomic Nervous System Function
Condition: Hypoglycemia
Interventions: Drug: Eplerenone;   Drug: Placebo
32 Recruiting A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
Condition: Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Metformin
33 Recruiting Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
34 Recruiting Liraglutide as add-on to Insulin in Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Liraglutide;   Drug: Placebo
35 Unknown  The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1
Condition: Pharmacogenetics of Metformin
Intervention: Drug: Metformin
36 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Metformin;   Drug: Placebo
37 Not yet recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
38 Recruiting A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
39 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
40 Unknown  Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
Condition: Type 2 Diabetes Mellitus
Interventions: Device: Tantalus;   Drug: Insulin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years